Canaccord Genuity Reiterates Buy Rating on Passage Bio Inc. (PASG)

September 17, 2024 6:42 AM EDT Send to a Friend
Canaccord Genuity analyst Whitney Ijem reiterated a Buy rating and $13.00 price target on Passage Bio Inc. (NASDAQ: PASG).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login